Abstract
Get full access to this article
View all access options for this article.
References
1.
Britton
HL
Schwinghammer
TL
Romano
MJ
. Cost containment through restriction of cephalosporins . Am J Hosp Pharm 1981 ; 38 :1897 –900 .
2.
Katz
E
Schlamowitz
S
. Savings achieved through cephalosporin surveillance . Am J Hosp Pharm 1978 ; 35 :1521 –3 .
3.
Steckel
SD
Siskin
SB
. A multicenter survey of cefazolin usage . Hosp Form 1981 ; 11 :1284 –93 .
4.
Martucci
HJ
Parry
MF
. Cephalosporin cost reduction . Hosp Form 1981 ; 4 :396 –403 .
5.
Suzuki
NT
Pelham
LD
. Cost benefit of pharmacist concurrent monitoring of cefazolin prescribing . Am J Hosp Pharm 1983 ; 40 :1187 –91 .
6.
Phelps
MR
Godwin
HN
. Pharmacy and therapeutics committee review of the parenteral cephalosporins . Am J Hosp Pharm 1978 ; 35 :73 –5 .
7.
Brooks
GF
Barriere
SL
. Clinical use of the new beta-lactam antimicrobial drugs . Ann Intern Med 1983 ; 98 :530 –5 .
8.
Counts
GN
. Review and control of antimicrobial usage in hospitalized patients . JAMA 1977 ; 238 :2170 –2 .